BioLine RX Ltd (NASDAQ:BLRX)

0.8578
Delayed Data
As of Apr 20
 -0.0021 / -0.24%
Today’s Change
0.80
Today|||52-Week Range
1.34
-21.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash5.8M5.5M2.5M5.1M
 
 
 
 
 
Short Term Investment Cash-2.3M-245.9K-3.1M2.7M
 
 
 
 
 
Cash & Short Term Investments34.7M47.7M35.6M49.5M
 
 
 
 
 
 
ReceivablesReceivables257.0K291.0K222.8K586.0K
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses220.7K229.0K254.8K307.0K
 
 
 
 
 
Current Assets35.1M48.2M36.1M50.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.7M3.9M4.0M4.4M
 
 
 
 
 
Depreciation-930.2K-954.0K-1.4M-1.8M
 
 
 
 
 
Intangible Assets117.4K152.0K180.8K7.0M
 
 
 
 
 
Other Assets166.3K210.0K232.8K7.1M
 
 
 
 
 
Total Assets36.2M51.3M38.9M61.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable--1.9M2.6M5.5M
 
 
 
 
Short Term Debt0.0093.0K92.9K93.0K
 
 
 
 
Accrued Expenses609.3K705.0K559.5K620.0K
 
 
 
 
 
Other Current Liabilities2.3M715.0K574.5K639.0K
 
 
 
 
 
Other Liabilities2.9M3.1M3.7M6.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.00344.0K249.8K157.0K
 
 
 
 
Other Liabilities1.5M208.0K999.061.2M
 
 
 
 
 
Total Liabilities4.4M3.7M3.9M8.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity31.8M47.6M35.0M52.9M
 
 
 
 
 
Total Shareholder Equity31.8M47.6M35.0M52.9M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding39.1M54.8M57.0M105.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.